Biotech

HR Tech World is NOW UNLEASH

24 October 2017, Amsterdam - HR Tech World, the fastest growing international show on the Future of Work today announces its rebrand as UNLEASH. The news comes today live from the flagship Amsterdam show, and was made in parallel with the closing keynote delivered by global thought leader Arianna Huffington. Alongside the adoption of its new brand and...

MiNiT Financial Services launches new world-class FinTech products at Money 20/20

SPARX GATEWAY LLC and CardNet Alliance exhibited at leading FinTech eventLas Vegas, USA, 23 October 2017: Macate Group Corporation, an American multinational corporation, and its affiliate MiNiT Financial Services, Inc. today announced the launch of two new, innovative FinTech products at Money 20/20 in Las Vegas. The SPARX GATEWAY LLC and CardNet Alliance,...

PAREXEL Ranked A Top CRO In CenterWatch Global Investigative Site Relationship Survey

Company recognised for sponsor/site relationship qualityLONDON, April 3, 2017 – PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services organisation, today announced that it was named a top contract research organisation (CRO) in the CenterWatch 2017 Global Investigative Site Relationship Survey. The survey...

PAREXEL Launches Patient Sensor Solution To Transform Clinical Trial Data Collection

Comprehensive wearables and sensors solution, powered by the Perceptive MyTrials® Analytics platform, creates greater efficiencies for biopharmaceutical companies LONDON, March 30, 2017 – PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced the launch of its patient sensor...

PAREXEL International appoints Simon Harford as Senior Vice President and Chief Financial Officer

Appointment Effective June 1, 2017LONDON, February 28, 2017 – PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced the appointment of Simon Harford as Senior Vice President and Chief Financial Officer effective June 1, 2017. He will serve on PAREXEL's Business Review Committee,...

PAREXEL Announces Definitive Agreement to Acquire The Medical Affairs Company

Acquisition will strengthen and add scale to current commercialisation and medical affairs servicesLONDON, February 2, 2017 – PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that the Company has entered into a definitive agreement to acquire The Medical Affairs Company, LLC...

PAREXEL Expands Managed Access Programs Service Offering

Simplified, end-to-end solution will help biopharmaceutical clients provide compassionate access to their treatments for patientsLondon, January 26, 2017 – PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today launched an expanded Managed Access Programs service. PAREXEL now offers end-to-end...

Sven Holmlund joins LemnaTec as Chairman

December 5th 2016, Aachen, Germany: Plant phenotyping specialist LemnaTec has announced the appointment of Sven Holmlund as Chairman.During his 16-year tenure as CEO of the Perten Instruments Group, a global supplier of advanced analytical instruments for quality control of food, Holmlund achieved impressive growth with sales in more than 100 countries...

Nature Methods publication features Intomics' proprietary Protein-Protein Interaction Network, InBio Map™

Lyngby, Nov. 30th, 2016: Nov. 28th, Nature Methods published (online) a comparative study of leading Protein-Protein Interaction (PPI) Networks. The publication entitled “A scored human protein-protein interaction network to catalyze genomic interpretation” finds Intomics’ InBio Map™ (entitled InWeb_IM in the publication) to...

PAREXEL Launches IDMP-Focused Software And Service Solution

Solution developed to help biopharmaceutical companies meet emerging regulatory requirements ahead of deadlineLONDON, November 14, 2016 – PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today launched an Identification of Medicinal Products (IDMP)-focused solution for biopharmaceutical companies....

PAREXEL Announces Execution Of Definitive Agreement To Acquire ExecuPharm

Acquisition will strengthen and add scale to current functional services offering to meet growing demandLondon, UK: September 26, 2016 – PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that the Company has entered into a definitive agreement to acquire ExecuPharm, Inc. (“ExecuPharm”),...

Cancer virotherapy medicine received the grant from European Commission in order to initiate the commercialization in the EU markets

European Commission awarded Latima with a grant for cancer virotherapy medicine commercialization in the EU markets within a framework of Horizon 2020 programme “Dedicated support to the biotechnology SMEs closing the gap from lab to market”.Horizon 2020 is the biggest EU Research and Innovation programme ever with nearly 80 billion euros...

BioConnect Solution Changes Security Game for New London Colocation Facility

Today BioConnect announces the successful deployment of its BioConnect Identity Platform and Suprema biometric hardware for access control at Netwise Hosting Ltd, a leading provider of data centre colocation in London, UK. BioConnect provides identity solutions, with a special focus on data centre colocation customers. BioConnect offers a unique approach...

Norbain Adds New Suprema and BioConnect Biometric Products to Access Control Portfolio

Norbain is pleased to announce the addition of new BioConnect biometric products to the Norbain product portfolio. BioConnect is on a ‘Quest for Rightful Identity’ seeking to empower people to authenticate with credentials that are completely unique to them, such as their face, eyes, voice, heartbeat or fingerprint throughout their everyday...

FDA Confirmed Speaking at Pre-Filled Syringes West Coast 2016!

SMi Group reports (2016.05.11, San Diego, California, USA): FDA will provide the latest updates on Pre-Filled Syringes and Combination Products at Pre-Filled Syringes West Coast 2016.SMi are delighted to announce that FDA will be presenting at Pre-Filled Syringes West Coast this June in San Diego. Tina Kiang, Ph.D., Deputy Director, Science and Policy,...

PAREXEL And EMC Form Alliance To Provide Cloud-Based Document And Regulatory Information Management Services

PAREXEL enhances its Regulatory Cloud; leverages EMC® Documentum® for Life Sciences software solution suite to offer an end-to-end regulatory solutionLONDON, 13th April, 2016 - PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services organisation, and EMC Corporation (NYSE: EMC) today announced they have...

PAREXEL Launches Expanded Genomic Research Services

London, February 17, 2016 - PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services organisation, today announced expanded services and capabilities in genomic-based drug development. The PAREXEL® Genomic Medicine team offers clients a variety of strategic and operational genomic research services to accelerate...